Claret Asset Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
1,058
+101
+11% +$21.7K 0.02% 444
2026
Q1
$212K Hold
957
0.03% 324
2025
Q4
$243K Sell
957
-2
-0.2% -$502 0.03% 274
2025
Q3
$237K Sell
959
-14
-1% -$3.35K 0.03% 302
2025
Q2
$234K Buy
973
+77
+9% +$17.9K 0.03% 288
2025
Q1
$203K Buy
+896
New +$197K 0.03% 279
2024
Q4
Sell
-889
Closed -$216K 346
2024
Q3
$216K Buy
+889
New +$208K 0.04% 273

Other funds holding STE

Claret Asset Management's STE Position: Q2 2026 in Review

Claret Asset Management increased its Steris (STE) stake by 11% in Q2 2026, buying an estimated $21.7K and bringing the position to 1,058 shares worth $223K. The position accounts for 0.02% of the portfolio, ranked #444.

Claret Asset Management first reported a position in STE in Q3 2024 and has held it in 7 quarters since. The position peaked at $243K in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Claret Asset Management held 1,058 shares of Steris worth $223K as of Q2 2026.
  • Claret Asset Management bought 101 Steris shares in Q2 2026, an estimated $21.7K.
  • Steris made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #444 holding.
  • Claret Asset Management first reported a position in Steris in Q3 2024 and has held it in 7 quarters since.
  • Claret Asset Management's Steris position peaked at $243K in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.